Breast cancer cell-derived exosomes were used to deliver S100A4 siRNA that led to significantly reduced postoperative breast cancer metastasis (121), and exosomes loaded with SCD-1 siRNA significantly promoted anaplastic thyroid carcinoma cell apoptosis by enhancing its intracellular ROS level (122). This evidence concerns the gene S100A4 and breast carcinoma.